Petrillo, Marco
 Distribuzione geografica
Continente #
EU - Europa 2.186
NA - Nord America 2.075
AS - Asia 861
SA - Sud America 148
AF - Africa 27
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 5.306
Nazione #
US - Stati Uniti d'America 2.052
DE - Germania 933
SE - Svezia 344
CN - Cina 336
SG - Singapore 284
UA - Ucraina 159
IT - Italia 157
FR - Francia 145
BR - Brasile 129
IE - Irlanda 100
GB - Regno Unito 87
PL - Polonia 81
ID - Indonesia 62
IN - India 62
RU - Federazione Russa 60
FI - Finlandia 51
TR - Turchia 41
BE - Belgio 20
CI - Costa d'Avorio 15
CA - Canada 14
HK - Hong Kong 11
IR - Iran 9
NL - Olanda 8
VN - Vietnam 6
AT - Austria 5
CH - Svizzera 5
CL - Cile 5
KR - Corea 5
PE - Perù 5
PH - Filippine 5
UZ - Uzbekistan 5
BD - Bangladesh 4
KE - Kenya 4
LV - Lettonia 4
MA - Marocco 4
MX - Messico 4
NO - Norvegia 4
SA - Arabia Saudita 4
AR - Argentina 3
AU - Australia 3
BG - Bulgaria 3
EC - Ecuador 3
EU - Europa 3
JP - Giappone 3
KZ - Kazakistan 3
TJ - Tagikistan 3
AE - Emirati Arabi Uniti 2
CY - Cipro 2
CZ - Repubblica Ceca 2
ES - Italia 2
GR - Grecia 2
IL - Israele 2
IQ - Iraq 2
IS - Islanda 2
KG - Kirghizistan 2
LU - Lussemburgo 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PA - Panama 2
RO - Romania 2
A1 - Anonimo 1
AM - Armenia 1
AO - Angola 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
EE - Estonia 1
HN - Honduras 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LT - Lituania 1
MD - Moldavia 1
MY - Malesia 1
NP - Nepal 1
PK - Pakistan 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TM - Turkmenistan 1
TN - Tunisia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 5.306
Città #
Chandler 568
Singapore 156
Ashburn 149
Jacksonville 117
Dublin 100
San Mateo 100
Nürnberg 74
Warsaw 73
Wilmington 73
Nanjing 72
Ann Arbor 66
Jakarta 61
New York 52
Dearborn 51
Marseille 47
Boston 38
Cattolica 35
Izmir 35
Houston 34
Los Angeles 30
Moscow 30
Lawrence 29
Beijing 27
Princeton 27
Brussels 20
Hangzhou 20
Redwood City 20
Seattle 19
Frankfurt am Main 17
Kunming 17
Boardman 16
Lancaster 16
Abidjan 15
Fairfield 15
Mountain View 15
Changsha 14
Helsinki 14
Nanchang 14
Norwalk 14
Rome 14
Munich 13
Tianjin 13
Woodbridge 13
Bremen 12
Hebei 12
Leawood 12
Milan 12
Shenyang 12
University Park 12
Hefei 10
Chicago 9
Detroit 9
Düsseldorf 9
Falls Church 9
Guangzhou 9
London 9
São Paulo 9
Hong Kong 8
Redmond 8
Bucchianico 7
Hyderabad 7
Jiaxing 7
Nuremberg 7
Belo Horizonte 6
Edinburgh 6
Jinan 6
Wuhan 6
Lauterbourg 5
Lima 5
Millbury 5
Ottawa 5
Pasig 5
Shanghai 5
Tashkent 5
Amsterdam 4
Augusta 4
Cambridge 4
Fremont 4
Genazzano 4
Paris 4
Riga 4
Saint Petersburg 4
San Francisco 4
Seoul 4
St Petersburg 4
The Dalles 4
Toronto 4
Wroclaw 4
Brasília 3
Busto Arsizio 3
Clearwater 3
Curitiba 3
Dushanbe 3
Indiana 3
Kish 3
Lanzhou 3
Mumbai 3
Newark 3
Perugia 3
Rio de Janeiro 3
Totale 2.683
Nome #
Prognostic role of topoisomerase-IIalpha in advanced ovarian cancer patients 256
Evaluation of quality of life and emotional distress in endometrial cancer patients: A 2-year prospective, longitudinal study 197
Paclitaxel, epirubicin, and cisplatin (TEP) regimen as neoadjuvant treatment in locally advanced cervical cancer: long-term results 184
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery 174
Quality of life and psychological distress in locally advanced cervical cancer patients administered pre-operative chemoradiotherapy 154
Prognostic role of Ca125 response criteria and RECIST criteria: analysis of results from the MITO-3 phase III trial of gemcitabine versus pegylated liposomal doxorubicin in recurrent ovarian cancer. 145
BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study 145
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 143
Secondary cytoreductive surgery in patients with isolated platinum-resistant recurrent ovarian cancer: A retrospective analysis 140
Influence of Intraperitoneal Dissemination Assessed by Laparoscopy on Prognosis of Advanced Ovarian Cancer: An Exploratory Analysis of a Single-Institution Experience 139
Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation? 134
Incidence and predictive factors for complications after uterine leiomyoma embolization 124
A complete pathological response to treatment in a young patient with locally advanced minimal deviation adenocarcinoma of the uterine cervix undergoing chemoradiation followed by radical surgery 123
Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: a prospective, longitudinal study 121
Secondary malignancies of the uterine cervix: a potential diagnostic pitfall 116
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 115
Prognostic role of the recepteur d'origine nantais (RON) expression in ovarian cancer patients 114
Mutational status of KRAS, NRAS, and BRAF in primary clear cell ovarian carcinoma 101
Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: A case-control study on survival in patients with two year follow-up 99
Minimally invasive versus standard laparotomic interval debulking surgery in ovarian neoplasm: A single-institution retrospective case-control study 99
Fertility-sparing surgery in ovarian cancer extended beyond the ovaries: a case report and review of the literature 97
Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective longitudinal analysis using matched tumor biopsie 95
Long-term prospective longitudinal evaluation of emotional distress and quality of life in cervical cancer patients who remained disease-free 2-years from diagnosis 94
Impact of bevacizumab containing first line chemotherapy on recurrent disease in epithelial ovarian cancer: A case-control study 92
Targeting the hallmarks of ovarian cancer: The big picture 88
Laparoscopic En Bloc Right Diaphragmatic Peritonectomy for Diaphragmatic Endometriosis According to the Sugarbaker Technique 86
Non-catalytic region of tyrosine kinase adaptor protein 2 (NCK2) pathways as factor promoting aggressiveness in ovarian cancer 84
FOXL2 molecular status in adult granulosa cell tumors of the ovary: A study of primary and metastatic cases 82
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic 80
Ovarian low and high grade serous carcinomas: hidden divergent features in the tumor microenvironment 77
Polarisation of Tumor-Associated Macrophages toward M2 Phenotype Correlates with Poor Response to Chemoradiation and Reduced Survival in Patients with Locally Advanced Cervical Cancer. 75
A combined ANXA2-NDRG1-STAT1 gene signature predicts response to chemoradiotherapy in cervical cancer 75
Robotic Total Mesometrial Resection versus Laparoscopic Total Mesometrial Resection in Early Cervical Cancer: A Case-Control Study 73
Uncovering the role of nuclear Lysyl oxidase (LOX) in advanced high grade serous ovarian cancer 73
Time trade-off procedure for measuring health utilities loss with human papillomavirus-induced diseases: a multicenter, retrospective, observational pilot study in Italy 72
Identification and antitumor activity of a novel inhibitor of the NIMA-related kinase NEK6 70
Robotic Versus Laparoscopic Staging for Early Ovarian Cancer: A Case Matched Control Study 67
Neoadjuvant Chemotherapy Followed by Maintenance Therapy With or Without Bevacizumab in Unresectable High-Grade Serous Ovarian Cancer: A Case-Control Study 66
Pathologic response to neoadjuvant chemotherapy in advanced ovarian cancer: utility of a scoring system to predict outcomes 66
Survivin protein as predictor of pathologic response in patients with locally advanced cervical cancer treated with chemoradiation followed by radical surgery 65
The relevance of prelamin A and RAD51 as molecular biomarkers in cervical cancer 65
Self-Reported Long-Term Autonomic Function After Laparoscopic Total Mesometrial Resection for Early-Stage Cervical Cancer: A Multicentric Study 64
Preoperative serum human epididymis protein 4 levels in early stage endometrial cancer: A prospective study 63
Preoperative Anti-Class III β-Tubulin Antibodies As Relevant Clinical Biomarkers in Ovarian Cancer 61
Secondary cytoreduction in ovarian cancer: who really benefits? 61
Laparoscopic laterally extended endopelvic resection procedure for gynecological malignancies 61
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 60
Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective longitudinal analysis using matched tumor biopsies 59
The safety of bevazicumab for the treatment of ovarian cancer 59
Systematic Review of Cytoreductive Surgery and Bevacizumab-Containing Chemotherapy in Advanced Ovarian Cancer: Focus on Safety 57
Long-Term Survival for Platinum-Sensitive Recurrent Ovarian Cancer Patients Treated with Secondary Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC) 53
Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: a prospective study 50
Role of extracellular vesicles in epithelial ovarian cancer: A systematic review 49
Incidence, predictors and clinical outcome of pancreatic fistula in patients receiving splenectomy for advanced or recurrent ovarian cancer: a large multicentric experience 47
Cytoreductive surgery plus platinum-based hyperthermic intraperitoneal chemotherapy in epithelial ovarian cancer: A promising integrated approach to improve locoregional control 46
RE: Pattern of and reason for postoperative residual disease in patients with advanced ovarian cancer following upfront radical debulking surgery 46
Restructuring surgical training after COVID-19 pandemic: A nationwide survey on the Italian scenario on behalf of the Italian polyspecialistic young surgeons society (SPIGC) 44
Patterns of Lymph Node Metastases in Apparent Stage I Low-Grade Epithelial Ovarian Cancer: A Multicenter Study 44
Role of CTGF in Sensitivity to Hyperthermia in Ovarian and Uterine Cancers 14
Totale 5.403
Categoria #
all - tutte 22.551
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.551


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202037 0 0 0 0 0 0 0 0 0 0 0 37
2020/2021377 28 37 15 25 58 15 48 9 41 19 73 9
2021/2022618 52 25 11 43 35 25 10 98 40 57 92 130
2022/20231.263 154 203 118 225 53 171 66 75 141 11 28 18
2023/2024500 28 142 8 22 11 73 41 13 9 30 59 64
2024/2025855 25 26 85 45 105 43 21 36 177 81 190 21
Totale 5.403